We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

CT Scans Beats Genetics at Predicting Heart Attack Risk

By MedImaging International staff writers
Posted on 24 May 2023
Print article
Image: CT scan is best at predicting heart disease risk in middle age (Photo courtesy of Freepik)
Image: CT scan is best at predicting heart disease risk in middle age (Photo courtesy of Freepik)

Traditionally, doctors have relied on standard risk-factor levels, such as blood pressure and cholesterol, to assess an individual's likelihood of developing coronary heart disease or heart artery blockages. However, these conventional methods can fail to identify some people at risk of heart attacks or other heart-related conditions. Given the hereditary nature of heart disease, scientists have been hopeful that a person's genetics could provide insight into who is most at risk. The concept of polygenic risk scores - a compilation of over 6 million common genetic variants associated with heart disease - was seen as a potential leap forward for personalized medicine. A recent study, however, has found that CT scans are more accurate than genetics in predicting a middle-aged person’s risk for heart disease, such as a heart attack.

In the study, researchers at Northwestern University (Evanston, IL, USA) directly compared the efficacy of genetics and CT scans for coronary artery calcium and demonstrated that the CT scan is superior to genetics at predicting heart disease risk in middle-aged individuals. The study incorporated data from 3,208 adults across two cohorts - one in the U.S. and the other in Rotterdam, Netherlands. This data included risk factors for heart disease (such as smoking status, cholesterol levels, and blood pressure), genetic information, and CT scan data to estimate the risk of developing heart disease over a follow-up period of up to 17 years.

The researchers examined how using either CT scans or polygenic risk scores altered the predicted risk of individuals based on conventional risk factors such as blood pressure and cholesterol. They investigated whether adding either of these markers (CT or genetics) shifted individuals into a different risk category. A low risk individual is defined as someone with less than a 7.5% risk of developing heart disease in the next decade. Those with a risk above 7.5% are typically recommended statins. The study found that genetic data did not affect a person’s risk category based on their conventional risk factors. However, when CT scan data was considered, half the study participants were reclassified into the high-risk group.

“Finding the best way to identify who is at risk for developing heart disease can help determine what needs to be done to lower their risk,” said lead study author Dr. Sadiya Khan, an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine cardiologist. “This finding can help doctors and patients in managing risk for heart disease, which is the leading cause of death in the U.S.”

“These findings support recommendations to consider CT screening to calculate risk for heart disease in middle-aged patients when their degree of risk is uncertain or in the intermediate range,” Khan said. “The data from the CT scan can help identify individuals who may benefit from medications, such as statins, to reduce their risk of heart disease.”

Related Links:
Northwestern University 

Gold Member
Solid State Kv/Dose Multi-Sensor
Portable Digital X-Ray System
Acuity PDR
Endoscopic Ultrasound Fine Needle Biopsy Device
Compact C-Arm
Arcovis DRF-C S21

Print article



view channel
Image: The artificial intelligence model outperformed clinical tests at predicting the progress of Alzheimer’s disease (Photo courtesy of 123RF)

AI Outperforms Clinical Tests at Predicting Alzheimer’s Progress from MRI Scans

Dementia is a major global health challenge, impacting over 55 million individuals worldwide and costing approximately USD 820 billion annually. Projections indicate that the number of cases will nearly... Read more


view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.